- 1. (123-I)Sodium Iodide
- [A radiopharmaceutical containing the radioisotope I-123 with diagnostic property. After absorption, the iodide is distributed through the extracellular fluid of the body and accumulates in the thyroid gland, thereby allowing measurement of thyroid function. ( NCI )] (UMLS (NCI) C0304977) =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical ;
=IODIDE (AS SODIUM IODIDE);
[DX202] NON-IMAGING AGENTS RADIOPHARMACEUTICALS =Sodium iodide I123 1 MIL;
Sodium iodide I123 0.2 MIL;
SODIUM IODIDE,I-123 100 MIC;
| - 51. ISO 2955.83 (units of measure) with HL7 extensions
- (UMLS (HL7) C1550222) =Intellectual Product =Code;
|
- 2. (131-I)Sodium Iodide
- [A radiopharmaceutical containing the beta- and gamma-emitting radioisotope I-131. After absorption, the iodide is distributed through the extracellular fluid of the body and accumulates in the thyroid gland, thereby allowing the imaging of the thyroid. ( NCI )] (UMLS (NCI) C0304982) =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical ;
=IODIDE (AS SODIUM IODIDE);
[DX201] IMAGING AGENTS (IN VIVO) RADIOPHARMACEUTICALS =Sodium iodide I131 0.067 MIL/ML;
Sodium iodide I131 100 MIC;
Sodium iodide I131 15 MIL;
Sodium iodide I131 1 MIL;
Sodium iodide I131 2 MIL/ML;
Sodium iodide I131 50 MIL;
Sodium iodide I131 7.05 MIL;
SODIUM IODIDE,I-131 8-100 MIC | - 52. ISO 3166 2 Character Country Codes
- [Two character country codes ( HL7V3.0 )] (UMLS (HL7) C1553718) =Intellectual Product =CodeSystem;
|
- 3. (2-Isothiocyanatoethyl)benzene
- [Phenethyl isothiocyanate. A naturally occurring compound found in some cruciferous vegetables. It is being studied as an agent to prevent cancer. ( NCI )] (UMLS (NCI) C0070558) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance
| - 53. ISO 3166 3 Character Country Codes
- [Three character country codes ( HL7V3.0 )] (UMLS (HL7) C1553719) =Intellectual Product =CodeSystem;
|
- 4. (6-Isothiocyanatohexyl)benzene
- (UMLS (NCI) C0099413) =Organic Chemical; Pharmacologic Substance ;
| - 54. ISO 3166 Numeric country Codes
- [Numeric country codes ( HL7V3.0 )] (UMLS (HL7) C1553720) =Intellectual Product =CodeSystem;
|
- 5. 1-(Isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol Hydrochloride
- [The hydrochloride salt form of betaxolol, a beta-1-selective adrenergic receptor antagonist without intrinsic sympathomimetic activity. Betaxolol hydrochloride acts on the heart and circulatory system and decreases cardiac contractility and rate, thereby reducing cardiac output. When applied topically in the eye, it lowers intraocular pressure by reducing aqueous humor secretion. ( NCI )] (UMLS (NCI) C0543470) =Organic Chemical; Pharmacologic Substance =1-(4-(2-Cyclopropylmethoxy)ethyl)phenoxy)-3-))1-methylethyl)amino)-2-propanol;
=BETAXOLOL HYDROCHLORIDE 0.25 %;
BETAXOLOL HYDROCHLORIDE 0.5 %;
BETAXOLOL HYDROCHLORIDE 10 MG;
BETAXOLOL HYDROCHLORIDE 20 MG;
| - 55. ISO 7064: 1983
- (UMLS (HL7) C1546486) =Intellectual Product =Check digit scheme;
|
- 6. 2-Isopropylaminopyrimidine
- (UMLS (NCI) C0063890) =Organic Chemical; Pharmacologic Substance ;
| - 56. ISO Defined Codes where nnnn is the ISO table number
- (UMLS (HL7) C1550223) =Intellectual Product =Code;
|
- 7. 3-Isoxazolecarboxylic Acid, 5-methyl-, 2-(phenylmethyl)hydrazide
- [A hydralazine and monoamine oxidase (MAO) inhibitor with antidepressant activity. Isocarboxazid blocks the breakdown (oxidative deamination) of biogenic amines by inhibiting MAO, thereby increasing the concentrations of norepinephrine and 5-hydroxytrytamine (5-HT) at central aminergic receptors. These neurotransmitters are involved in sustaining mood and emotions. The down-regulation of central beta-adrenergic and serotonergic receptors by chronic inhibition of MAO may also contribute to the antidepressant effects seen by isocarboxazid. (NCI05) ( NCI )] (UMLS (NCI) C0022154) =Organic Chemical; Pharmacologic Substance ;
=isoxazole;
[CN602] MONOAMINE OXIDASE INHIBITOR ANTIDEPRESSANTS =ISOCARBOXAZID 10 MG;
| - 57. ISO Object Identifier
- [Object identifier assigned to a concept ( HL7V3.0 )] (UMLS (HL7) C1553882) =Idea or Concept =HL7 Value Set and Coded Concept Property Codes;
|
- 8. 4-Isoxazolecarboxamide, 5-Methyl-N-(4-(trifluoromethyl)phenyl)-
- [An anticancer drug that works by inhibiting a cancer cell growth factor. Also called SU101. ( NCI )] (UMLS (NCI) C0063041) =Organic Chemical; Pharmacologic Substance ;
=isoxazole;
[MS109] ANTIRHEUMATICS, OTHER =LEFLUNOMIDE 10 MG;
LEFLUNOMIDE 20 MG;
LEFLUNOMIDE 100 MG | - 58. ISO-10646-UCS-2
- [Deprecated for HL7 use. ( HL7V3.0 )] (UMLS (HL7) C1555006) =Intellectual Product =Charset;
|
- 9. 5-isoandrosterone
- [A 17-ketosteroid which excreted in the urine as a metabolite of steroid hormones. The most common form of etiocholanolone present in the urine is the sulfate salt. This agent, also known as 5-isoandrosterone, may be used to evaluate adrenal cortex function, bone marrow performance and, in neoplastic disease, for immunostimulation. (NCI04) ( NCI )] (UMLS (NCI) C0015124) =Steroid; Hormone ;
| - 59. ISO-10646-UCS-4
- [Deprecated for HL7 use. ( HL7V3.0 )] (UMLS (HL7) C1555007) =Intellectual Product =Charset;
|
- 10. 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1)
- [The oxalate salt of escitalopram, a pure S-enantiomer of the racemic bicyclic phthalane derivative citalopram, with antidepressant activity. As a selective serotonin reuptake inhibitor (SSRI), escitalopram blocks the reuptake of serotonin by neurons in the central nervous system (CNS), thereby potentiating CNS serotonergic activity. ( NCI )] (UMLS (NCI) C1170746) Escitalopram Oxalate;
ESCITALOPRAM OXALATE UNIDENTIFIED;
ESCITALOPRAM OXALATE PREPARATION;
ESCITALOPRAM OXALATE UNIDENTIFIED =Organic Chemical; Pharmacologic Substance =ESCITALOPRAM;
Unclassified Ingredients =Escitalopram 10 MG Oral Tablet;
Escitalopram 5 MG Oral Tablet;
Escitalopram 20 MG Oral Tablet;
Escitalopram 1 MG/ML Oral Solution | - 60. ISO-8859-1
- [HL7 is indifferent to the use of this Charset. ( HL7V3.0 )] (UMLS (HL7) C1555009) =Intellectual Product =Charset;
|
- 11. Is
- [Supernumerary maxillary left first primary molar ( HL7V3.0 )] (UMLS (HL7) C1556119) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 61. ISO-8859-2
- [HL7 is indifferent to the use of this Charset. ( HL7V3.0 )] (UMLS (HL7) C1555010) =Intellectual Product =Charset;
|
- 12. IS (insertion sequence)
- [endogenous DNA sequences able to be excised from one place and inserted at another place in the genome (transposons), or exogenous, usually viral sequences able to be inserted regardless of complementarity to endogenous genes. ( CSP )] (UMLS (CSP) C0178868) =Gene or Genome ;
=gene;
| - 62. ISO-8859-5
- [HL7 is indifferent to the use of this Charset. ( HL7V3.0 )] (UMLS (HL7) C1555011) =Intellectual Product =Charset;
|
- 13. is appendage
- [An addendum (source) to an existing service object (target), containing supplemental information. The addendum is itself an original service object linked to the supplemented service object. The supplemented service object remains in place and its content and status are unaltered. ( HL7V3.0 )] (UMLS (HL7) C1550540) =Idea or Concept =is sequel;
| - 63. ISO4217
- [ISO 4217 currency code ( HL7V3.0 )] (UMLS (HL7) C1553869) =Intellectual Product =CodeSystem;
|
- 14. is backup for
- [This relationship indicates the source Role is available to the target Role as a backup. An entity in a backup role will be available as a substitute or replacement in the event that the entity assigned the role is unavailable. In medical roles where it is critical that the function be performed and there is a possibility that the individual assigned may be ill or otherwise indisposed, another individual is assigned to cover for the individual originally assigned the role. A backup may be required to be identified, but unless the backup is actually used, he/she would not assume the assigned entity role. ( HL7V3.0 )] (UMLS (HL7) C1552560) =Idea or Concept ;
=RoleLinkType;
| - 64. isoalloxazine
- [ ] (UMLS (CSP) C0063910) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
|
- 15. is derived from
- [Associates a derived Act with its input parameters. E.G., an anion-gap observation can be associated as being derived from given sodium-, (potassium-,), chloride-, and bicarbonate-observations. The narrative content (Act.text) of a source act is wholly machine-derived from the collection of target acts. ( HL7V3.0 )] (UMLS (HL7) C1550535) =Idea or Concept =has pertinent information;
| - 65. isoantigen
- [antigen carried by an individual, which is capable of eliciting an immune response in genetically different individuals of the same species but not in the individual bearing it. ( CSP )] (UMLS (CSP) C0022145) =Immunologic Factor =antigen;
=blood group antigen;
histocompatibility antigen |
- 16. is etiology for
- [An assertion that a new observation was assumed to be the cause for another existing observation. The assumption is attributed to the same actor who asserts the observation. This is stronger and more specific than the support link. For example, a growth of Staphylococcus aureus may be considered the cause of an abscess. The source (cause) is typically an observation, but may be any service, while the target must be an observation. ( HL7V3.0 )] (UMLS (HL7) C1562189) =Idea or Concept =has pertinent information;
| - 66. Isobrucein B
- [A quassinoid phytochemical isolated from the tropical plant Cedronia granatensis with potential antineoplastic and chemopreventive activities. (NCI04) ( NCI )] (UMLS (NCI) C0653458) =Organic Chemical
|
- 17. is manifestation of
- [An assertion that a new observation may be the manifestation of another existing observation or action. This assumption is attributed to the same actor who asserts the manifestation. This is stronger and more specific than an inverted support link. For example, an agitated appearance can be asserted to be the manifestation (effect) of a known hyperthyroxia. This expresses that one might not have realized a symptom if it would not be a common manifestation of a known condition. The target (cause) may be any service, while the source (manifestation) must be an observation. ( HL7V3.0 )] (UMLS (HL7) C1562064) =Idea or Concept =has pertinent information;
| - 67. Isochromosome
- [Metacentric chromosomes produced during MEIOSIS or MITOSIS when the CENTROMERE splits transversely instead of longitudinally. The chromosomes produced by this abnormal division are one chromosome having the two long arms of the original chromosome, but no short arms, and the other chromosome consisting of the two short arms and no long arms. Each of these isochromosomes constitutes a simultaneous duplication and deletion. ( MSH )] (UMLS (NCI) C0242621) =Acquired Abnormality ;
=Aberrant Chromosome;
|
- 18. is occurrence of
- [The source act is a single occurrence of a repeatable target act. The source and target act can be in any mood on the "completion track" but the source act must be as far as or further along the track than the target act (i.e., the occurrence of an intent can be an event but not vice versa). ( HL7V3.0 )] (UMLS (HL7) C1554210) occurrence;
=Idea or Concept =fulfills;
| - 68. isocitrate
- [ ] (UMLS (CSP) C0022160) =Organic Chemical
|
- 19. is sequel
- [An act relationship indicating that the source act follows the target act. The source act should in principle represent the same kind of act as the target. Source and target need not have the same mood code (mood will often differ). The target of a sequel is called antecedent. Examples for sequel relationships are: revision, transformation, derivation from a prototype (as a specialization is a derivation of a generalization), followup, realization, instantiation. ( HL7V3.0 )] (UMLS (HL7) C1550538) =Idea or Concept =ActRelationshipType;
=documents;
replaces;
is appendage;
updates (condition);
instantiates (master);
fulfills;
matches (trigger);
evaluates (goal);
has option;
has generalization;
Excerpts;
episodeLink;
transformation;
reverses;
| - 69. isocitrate dehydrogenase
- [converts isocitrate to alpha ketoglutarate. ( CSP )] (UMLS (CSP) C0022157) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol oxidoreductase;
respiratory enzyme |
- 20. is smaller than
- [The source concept code is "less than" the target concept in a strictly ordinal sense. ( HL7V3.0 )] (UMLS (HL7) C1553887) =Idea or Concept =Possible Concept Code Relationships;
| - 70. isocyanate
- [compound that contains the -N=C=O radical. ( CSP )] (UMLS (CSP) C0162344) =Organic Chemical ;
=cyanate;
|
- 21. ISA-51
- [A water-in-oil emulsion that stimulates the T-cell immune response to antigens and may be used in various types of cancer vaccines. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42976&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42976&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1573" NCI Thesaurus) ( PDQ )] (UMLS (NCI) C1311732) Montanide ISA 51;
Montanide ISA-51 =Organic Chemical; Pharmacologic Substance ;
| - 71. isocyanates
- (UMLS (HL7) C1696722) =Intellectual Product =EntityCode;
|
- 22. ISBT
- [International Society of Blood Transfusion. Blood Group Terminology 1990. VOX Sanquines 1990 58(2):152-169. ( HL7V3.0 )] (UMLS (HL7) C1550215) =Intellectual Product =Code;
CodeSystem | - 72. isocyanide
- [ ] (UMLS (CSP) C0022164) =Inorganic Chemical
|
- 23. ISBT 128 codes where nnnn specifies a specific table within ISBT 128.
- (UMLS (HL7) C1550216) =Intellectual Product =Code;
| - 73. isoelectric point
- [condition in which a substance has a neutral charge; pH level above which the substance would act as a base and below which it would act as an acid. ( CSP )] (UMLS (CSP) C0022171) =Quantitative Concept =Chemical Properties;
|
- 24. Isbufylline
- (UMLS (NCI) C0043937) =Organic Chemical; Pharmacologic Substance ;
| - 74. isoenzyme
- [different form of the same enzyme, such as from another tissue or species, membrane-bound vs. soluble, secreted vs. intracellular, or oligomerized to a different degree. ( CSP )] (UMLS (CSP) C0022173) =Amino Acid, Peptide, or Protein; Enzyme ;
=enzyme structure;
|
- 25. Iscador
- (UMLS (NCI) C0063891) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 75. ISOETHARINE
- [A beta-adrenergic receptor agonist with bronchodilator activity. Isoetharine selectively binds to beta-2 adrenergic receptors in bronchial smooth muscle, thereby activating intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP levels cause relaxation of bronchial smooth muscle, relieve bronchospasms, improve mucociliary clearance and reduce mediator substance release from inflammatory cells, especially from mast cells. ( NCI )] (UMLS (NCI) C0022176) =Organic Chemical; Pharmacologic Substance ;
=Amino Alcohols;
[RE102] BRONCHODILATORS, SYMPATHOMIMETIC,INHALATION =ISOETHARINE MESYLATE;
ISOETHARINE HYDROCHLORIDE;
ISOETHARINE MESYLATE;
ISOETHARINE HYDROCHLORIDE |
- 26. ischemia
- [blood deficiency in an organ or tissue caused by a constriction or obstruction of its blood vessels. ( CSP )] (UMLS (CSP) C0022116) =Disease or Syndrome =blood vessel disorder;
=Disease, ischemic heart;
cerebral ischemia/hypoxia;
ischemic preconditioning;
liver ischemia/hypoxia;
lung ischemia/hypoxia;
renal ischemia/hypoxia;
Brain Ischemia;
COMPARTMENT SYNDROME NOS;
Reperfusion Injury;
Disease, ischemic heart;
Ischemic optic neuropathy;
Colitis, Ischemic;
Spinal Cord Ischemia;
| - 76. Isofezolac
- (UMLS (NCI) C0124087) =Organic Chemical; Pharmacologic Substance ;
|
- 27. Ischemic Bowel Disease
- (UMLS (NCI) C0156149) =Disease or Syndrome ;
| - 77. Isoflavone
- [Plant compounds that are found in soy products. Soy isoflavones are being studied to see if they help prevent cancer. ( NCI )] (UMLS (NCI) C0022179) =Organic Chemical; Pharmacologic Substance ;
|
- 28. Ischemic Neuropathy
- (UMLS (NCI) C0238309) =Disease or Syndrome
| - 78. ISOFLURANE
- [F2CHOCHCl-CF3; used as an inhalation anesthetic; may act via beta adrenergic or muscarinic receptors; adverse side effects are hypotension and risk of myocardial ischemia and cardiac arrest. ( CSP )] (UMLS (NCI) C0022180) =Organic Chemical; Pharmacologic Substance ;
=[CN200] ANESTHETICS;
Methyl Ethers;
[CN201] ANESTHETICS INHALATION;
haloether =I 653;
ISOFLURANE 99.9 % |
- 29. Ischemic optic neuropathy
- [Ischemic injury to the OPTIC NERVE which usually affects the OPTIC DISK (optic neuropathy, anterior ischemic) and less frequently the retrobulbar portion of the nerve (optic neuropathy, posterior ischemic). The injury results from occlusion of arterial blood supply which may result from TEMPORAL ARTERITIS; ATHEROSCLEROSIS; COLLAGEN DISEASES; EMBOLISM; DIABETES MELLITUS; and other conditions. The disease primarily occurs in the sixth decade or later and presents with the sudden onset of painless and usually severe monocular visual loss. Anterior ischemic optic neuropathy also features optic disk edema with microhemorrhages. The optic disk appears normal in posterior ischemic optic neuropathy. (Glaser, Neuro-Ophthalmology, 2nd ed, p135) ( MSH )] (UMLS (ICD9CM) C0155305) =Disease or Syndrome =ischemia;
Optic Nerve Diseases | - 79. Isoform
- [Refers to variants of the same protein which can be separated on special conducting media using electrophoresis. The differences may arise from genetically determined differences in primary structure or by modification of the same primary sequence. ( NCI )] (UMLS (NCI) C0597298) =Amino Acid, Peptide, or Protein =amino acid sequence;
|
- 30. ischemic preconditioning
- [process by which tissue is rendered resistant to the deleterious effects of prolonged ischemia and reperfusion by prior exposure to brief, transient period(s) of ischemia. ( CSP )] (UMLS (CSP) C0376466) =Therapeutic or Preventive Procedure =ischemia;
| - 80. Isogel
- (UMLS (NCI) C0022182) =Pharmacologic Substance; Biologically Active Substance ;
|
- 31. Ischiocapsular (ligament) sprain
- [ ] (UMLS (ICD9CM) C0160076) =Injury or Poisoning
| - 81. Isoimmunization from other and unspecified blood-group incompatibility affecting management of mother
- [ ] (UMLS (ICD9CM) C0157108) =Disease or Syndrome
|
- 32. Ischiocavernosus
- (UMLS (NCI) C0224401) =Body Part, Organ, or Organ Component
| - 82. Isokinetic Exercise
- [An exercise that involves movement at a constant rate with a variable force throughout a specified range of motion. The advantage of this exercise is that it stresses the muscle being used throughout the entire range. (Kanner) ( NCI )] (UMLS (NCI) C0454287) =Therapeutic or Preventive Procedure
|
- 33. ISDN PCM audio data
- (UMLS (HL7) C1548450) =Intellectual Product =Subtype of referenced data;
| - 83. ISOL TRACH TB-EXAM UNKN
- [ ] (UMLS (ICD9CM) C0152636) =Disease or Syndrome
|
- 34. Iseganan HCl Oral Solution
- (UMLS (NCI) C1135119) =Clinical Drug ;
| - 84. ISOL TRACHEAL TB-CULT DX
- [ ] (UMLS (ICD9CM) C0152638) =Disease or Syndrome
|
- 35. iseganan hydrochloride
- [A substance that is being studied as a treatment for oral mucositis (painful mouth sores) caused by cancer therapy. It belongs to the family of drugs called synthetic protegrin analogs. ( NCI )] (UMLS (NCI) C1134510) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 85. ISOL TRACHEAL TB-NO EXAM
- [ ] (UMLS (ICD9CM) C0152635) =Disease or Syndrome
|
- 36. ISG
- (UMLS (HL7) C1548872) =Health Care Activity =Consent Type;
| - 86. ISOL TRACHEAL TB-UNSPEC
- [ ] (UMLS (ICD9CM) C0152634) =Disease or Syndrome
|
- 37. ISIS 2503
- [A substance that is being studied in the treatment of cancer. ( NCI )] (UMLS (NCI) C0879385) ISIS-2503;
=Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 87. ISOLAT TRACH TB-HISTO DX
- [ ] (UMLS (ICD9CM) C0152639) =Disease or Syndrome
|
- 38. ISIS 2922
- (UMLS (NCI) C0950924) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 88. ISOLAT TRACH TB-MICRO DX
- [ ] (UMLS (ICD9CM) C0152637) =Disease or Syndrome
|
- 39. ISIS 3521
- [A substance that is being studied in the treatment of cancer. ( NCI )] (UMLS (NCI) C0666551) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 89. ISOLAT TRACH TB-OTH TEST
- [ ] (UMLS (ICD9CM) C0152640) =Disease or Syndrome
|
- 40. ISIS 5132
- [A substance that is being studied in the treatment of cancer. ( NCI )] (UMLS (NCI) C0389883) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 90. Isolate
- (UMLS (HL7) C1546680) =Intellectual Product =Specimen Source Codes;
|
- 41. Islam
- [A monotheistic religion promulgated by the Prophet Mohammed with Allah as the deity. ( MSH )] (UMLS (HL7) C0022126) =Idea or Concept =religion;
Religious Affiliation | - 91. isolate
- [A microorganism that has been isolated from other microorganisms or a source matrix. ( HL7V3.0 )] (UMLS (HL7) C1764827) =Idea or Concept ;
=specimen;
SpecimenEntityType |
- 42. Island
- [A land mass smaller than a continent that is surrounded by water. ( NCI )] (UMLS (NCI) C0022130) =Geographic Area
| - 92. Isolate
- [A specific individual microbe and its genetically identical progeny separated on a single occasion from a sample taken from a host or culture system. ( NCI )] (UMLS (NCI) C0370215) =Substance ;
|
- 43. Islet Cell Adenomatosis
- [An inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the PANCREAS and PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY. It is due to focal hyperplasia of pancreatic ISLET CELLS budding off from the ductal structures and forming new islets of Langerhans. Mutations in the islet cells involve the potassium channel gene KCNJ11 or the ATP-binding cassette transporter gene ABCC8, both on CHROMOSOME 11. ( MSH )] (UMLS (NCI) C0027773) =Disease or Syndrome ;
| - 93. Isolated
- (UMLS (HL7) C1548221) =Idea or Concept =Bed Status;
|
- 44. Islet Cell Gastrinoma
- [A usually malignant pancreatic endocrine neoplasm, characterised by inappropriate secretion of gastrin. It is associated with Zollinger Ellison syndrome. The latter is characterised by the presence of peptic ulcer, gastroesophageal reflux disease, abdominal pain, diarrhea, and malabsorption. — 2005 ( NCI )] (UMLS (NCI) C1368066) Pancreatic Gastrin Producing Neoplasm;
Pancreatic Gastrin Producing Tumor;
Pancreatic Gastrinoma;
Pancreatic G-Cell Tumor =Neoplastic Process | - 94. Isolated
- [A state of separation; the act of isolating something; setting something apart from others; marked by separation of or from usually contiguous elements. ( NCI )] (UMLS (NCI) C0205409) =Functional Concept
|
- 45. Islet Cell Neoplasm
- [An uncommon benign or malignant neoplasm, arising from the islet cells of the pancreas. Based on the clinical manifestations, it is classified as functioning or non-functioning. ( NCI )] (UMLS (NCI) C0242363) =Neoplastic Process ;
| - 95. ISOLATED EXPLOSIVE DIS
- [ ] (UMLS (ICD9CM) C0154610) =Mental or Behavioral Dysfunction
|
- 46. Islet Cell WDHA Syndrome
- (UMLS (NCI) C0086768) =Disease or Syndrome ;
| - 96. Isolated Limb Perfusion
- [(per-FYOO-zhun) A technique that may be used to deliver anticancer drugs directly to an arm or leg. The flow of blood to and from the limb is temporarily stopped with a tourniquet, and anticancer drugs are put directly into the blood of the limb. This allows the person to receive a high dose of drugs in the area where the cancer occurred. Also called isolated limb perfusion. ( NCI )] (UMLS (NCI) C0396670) =Therapeutic or Preventive Procedure
|
- 47. islets of Langerhans adenoma
- [ ] (UMLS (CSP) C0599068) =Neoplastic Process ;
| - 97. Isolated Osseous Plasmacytoma
- [A localized clonal (malignant) plasma cell infiltrate in the bone without peripheral blood involvement. The most commonly affected bones are the vertebrae, ribs, skull, pelvis and femur. X-rays examination reveals a solitary lytic lesion. —2003 ( NCI )] (UMLS (NCI) C0272256) =Neoplastic Process
|
- 48. islets of Langerhans transplantation
- [transferring pancreatic islet cells within an individual or between individuals of the same or different species. ( CSP )] (UMLS (NCI) C0079646) =Therapeutic or Preventive Procedure ;
=pancreas grafting;
| - 98. Isolated Perfusion
- [extracorporeal circuit with temporary exclusion of the area from the general circulation during which high concentrations of drug are perfused to the isolated part; can be used in cancer therapy. ( CSP )] (UMLS (NCI) C0031006) =Therapeutic or Preventive Procedure ;
=extracorporeal circulation;
perfusion |
- 49. ISMO
- (UMLS (NCI) C0699156) =Organic Chemical; Pharmacologic Substance ;
| - 99. ISOLATED/SPEC PHOBIA NEC
- [ ] (UMLS (ICD9CM) C1456315) Other isolated or specific phobias;
=Mental or Behavioral Dysfunction |
- 50. ISO 11073-10101 Health informatics - Point-of-care
- [The nomenclature relates primarily to vital signs monitoring, but also includes semantics of other medical devices that are commonly used in acute care settings. There are multiple coding partitions each of which has a systematic name consisting of a set of base concepts and differentiating criteria. ( HL7V3.0 )] (UMLS (HL7) C1553860) =Intellectual Product =CodeSystem;
| - 100. Isolation
- (UMLS (HL7) C1548355) =Biomedical Occupation or Discipline =Specialty Type;
|
home
